Literature DB >> 19222480

The role of the Na+/Ca2+ exchanger, I(Na) and I(CaL) in the genesis of dofetilide-induced torsades de pointes in isolated, AV-blocked rabbit hearts.

Attila S Farkas1, Péter Makra, Norbert Csík, Szabolcs Orosz, Michael J Shattock, Ferenc Fülöp, Tamás Forster, Miklós Csanády, Julius Gy Papp, András Varró, András Farkas.   

Abstract

BACKGROUND AND
PURPOSE: The Na+/Ca2+ exchanger (NCX) may contribute to triggered activity and transmural dispersion of repolarization, which are substrates of torsades de pointes (TdP) type arrhythmias. This study examined the effects of selective inhibition of the NCX by SEA0400 on the occurrence of dofetilide-induced TdP. EXPERIMENTAL APPROACH: Effects of SEA0400 (1 micromol x L(-1)) on dofetilide-induced TdP was studied in isolated, Langendorff-perfused, atrioventricular (AV)-blocked rabbit hearts. To verify the relevance of the model, lidocaine (30 micromol x L(-1)) and verapamil (750 nmol x L(-1)) were also tested against dofetilide-induced TdP. KEY
RESULTS: Acute AV block caused a chaotic idioventricular rhythm and strikingly increased beat-to-beat variability of the RR and QT intervals. SEA0400 exaggerated the dofetilide-induced increase in the heart rate-corrected QT interval (QTc) and did not reduce the incidence of dofetilide-induced TdP [100% in the SEA0400 + dofetilide group vs. 75% in the dofetilide (100 nmol x L(-1)) control]. In the second set of experiments, verapamil further increased the dofetilide-induced QTc prolongation and neither verapamil nor lidocaine reduced the dofetilide-induced increase in the beat-to-beat variability of the QT interval. However, lidocaine decreased and verapamil prevented the development of dofetilide-induced TdP as compared with the dofetilide control (TdP incidence: 13%, 0% and 88% respectively). CONCLUSIONS AND IMPLICATIONS: Na+/Ca2+ exchanger does not contribute to dofetilide-induced TdP, whereas Na+ and Ca2+ channel activity is involved in TdP genesis in isolated, AV-blocked rabbit hearts. Neither QTc prolongation nor an increase in the beat-to-beat variability of the QT interval is a sufficient prerequisite of TdP genesis in rabbit hearts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19222480      PMCID: PMC2697716          DOI: 10.1111/j.1476-5381.2008.00096.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

1.  I(NaCa) contributes to electrical heterogeneity within the canine ventricle.

Authors:  A C Zygmunt; R J Goodrow; C Antzelevitch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-05       Impact factor: 4.733

2.  Proarrhythmic potential of halofantrine, terfenadine and clofilium in a modified in vivo model of torsade de pointes.

Authors:  Andrew J Batey; Susan J Coker
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

3.  Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.

Authors:  Peter Milberg; Lars Eckardt; Hans-Jürgen Bruns; Julia Biertz; Shahram Ramtin; Nico Reinsch; Dirk Fleischer; Paulus Kirchhof; Larissa Fabritz; Günter Breithardt; Wilhelm Haverkamp
Journal:  J Pharmacol Exp Ther       Date:  2002-10       Impact factor: 4.030

Review 4.  Assessing predictors of drug-induced torsade de pointes.

Authors:  Luiz Belardinelli; Charles Antzelevitch; Marc A Vos
Journal:  Trends Pharmacol Sci       Date:  2003-12       Impact factor: 14.819

5.  Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs.

Authors:  Morten B Thomsen; S Cora Verduyn; Milan Stengl; Jet D M Beekman; Geert de Pater; Jurren van Opstal; Paul G A Volders; Marc A Vos
Journal:  Circulation       Date:  2004-10-11       Impact factor: 29.690

6.  Does QT widening in the Langendorff-perfused rat heart represent the effect of repolarization delay or conduction slowing?

Authors:  András Farkas; Michael J Curtis
Journal:  J Cardiovasc Pharmacol       Date:  2003-11       Impact factor: 3.105

7.  Prolonged action potential durations, increased dispersion of repolarization, and polymorphic ventricular tachycardia in a mouse model of proarrhythmia.

Authors:  Larissa Fabritz; Paulus Kirchhof; Michael R Franz; Lars Eckardt; Gerold Mönnig; Peter Milberg; Günter Breithardt; Wilhelm Haverkamp
Journal:  Basic Res Cardiol       Date:  2003-02       Impact factor: 17.165

8.  Protective effects of SEA0400, a novel and selective inhibitor of the Na+/Ca2+ exchanger, on myocardial ischemia-reperfusion injuries.

Authors:  Kenzo Takahashi; Teisuke Takahashi; Taizo Suzuki; Michihito Onishi; Yu Tanaka; Akiko Hamano-Takahashi; Tomomi Ota; Kazuya Kameo; Toshio Matsuda; Akemichi Baba
Journal:  Eur J Pharmacol       Date:  2003-01-01       Impact factor: 4.432

9.  Attenuation of proarrhythmias related to delayed repolarization by low-dose lidocaine in the anesthetized rabbit.

Authors:  L Carlsson; L Drews; G Duker; G Schiller-Linhardt
Journal:  J Pharmacol Exp Ther       Date:  1993-12       Impact factor: 4.030

10.  Effects of sodium-calcium exchange inhibitors, KB-R7943 and SEA0400, on aconitine-induced arrhythmias in guinea pigs in vivo, in vitro, and in computer simulation studies.

Authors:  Md Shah Amran; Keitaro Hashimoto; Nobuo Homma
Journal:  J Pharmacol Exp Ther       Date:  2004-03-17       Impact factor: 4.030

View more
  13 in total

1.  Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective.

Authors:  Katja E Odening; Bum-Rak Choi; Gong Xin Liu; Kathryn Hartmann; Ohad Ziv; Leonard Chaves; Lorraine Schofield; Jason Centracchio; Manfred Zehender; Xuwen Peng; Michael Brunner; Gideon Koren
Journal:  Heart Rhythm       Date:  2012-01-11       Impact factor: 6.343

2.  Absolute beat-to-beat variability and instability parameters of ECG intervals: biomarkers for predicting ischaemia-induced ventricular fibrillation.

Authors:  Annamária Sarusi; Ferenc Rárosi; Mónika Szűcs; Norbert Csík; Attila S Farkas; Julius Gy Papp; András Varró; Tamás Forster; Michael J Curtis; András Farkas
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

3.  Biomarkers and endogenous determinants of dofetilide-induced torsades de pointes in α(1) -adrenoceptor-stimulated, anaesthetized rabbits.

Authors:  Attila S Farkas; László Rudas; Péter Makra; Norbert Csík; István Leprán; Tamás Forster; Miklós Csanády; Julius Gy Papp; András Varró; András Farkas
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

4.  The anaesthetized rabbit with acute atrioventricular block provides a new model for detecting drug-induced Torsade de Pointes.

Authors:  Mihoko Hagiwara; Seiji Shibuta; Kazuhiro Takada; Ryuichi Kambayashi; Misako Nakajo; Megumi Aimoto; Yoshinobu Nagasawa; Akira Takahara
Journal:  Br J Pharmacol       Date:  2017-07-05       Impact factor: 8.739

5.  Progesterone pretreatment reduces the incidence of drug-induced torsades de pointes in atrioventricular node-ablated isolated perfused rabbit hearts.

Authors:  James E Tisdale; Heather A Jaynes; Brian R Overholser; Kevin M Sowinski; Richard J Kovacs
Journal:  J Cardiovasc Electrophysiol       Date:  2019-04-21

6.  Co-expression of calcium and hERG potassium channels reduces the incidence of proarrhythmic events.

Authors:  Sara Ballouz; Melissa M Mangala; Matthew D Perry; Stewart Heitmann; Jesse A Gillis; Adam P Hill; Jamie I Vandenberg
Journal:  Cardiovasc Res       Date:  2021-08-29       Impact factor: 10.787

Review 7.  Minimizing repolarization-related proarrhythmic risk in drug development and clinical practice.

Authors:  Attila S Farkas; Stanley Nattel
Journal:  Drugs       Date:  2010-03-26       Impact factor: 9.546

8.  Selective Na(+) /Ca(2+) exchanger inhibition prevents Ca(2+) overload-induced triggered arrhythmias.

Authors:  Norbert Nagy; Anita Kormos; Zsófia Kohajda; Áron Szebeni; Judit Szepesi; Piero Pollesello; Jouko Levijoki; Károly Acsai; László Virág; Péter P Nánási; Julius Gy Papp; András Varró; András Tóth
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

9.  Chronic intermittent tachypacing by an optogenetic approach induces arrhythmia vulnerability in human engineered heart tissue.

Authors:  Marta Lemme; Ingke Braren; Maksymilian Prondzynski; Bülent Aksehirlioglu; Bärbel M Ulmer; Mirja L Schulze; Djemail Ismaili; Christian Meyer; Arne Hansen; Torsten Christ; Marc D Lemoine; Thomas Eschenhagen
Journal:  Cardiovasc Res       Date:  2020-07-01       Impact factor: 10.787

10.  New antiarrhythmic targets to control intracellular calcium handling.

Authors:  H E Driessen; V J A Bourgonje; T A B van Veen; M A Vos
Journal:  Neth Heart J       Date:  2014-05       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.